Vedolizumab for the Treatment of IBD: A Selective Therapeutic Approach Targeting Pathogenic a4b7 Cells

E-ISSN： 1873-5592|14|12|1433-1443

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.12, 2013-11, pp. : 1433-1443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strategies for Targeting IL-4 as a Novel Therapeutic Approach for the Treatment of Atopic Dermatitis

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 1, Iss. 1, 2002-04 ,pp. : 41-53

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutic targets in the treatment of IBD

By Kaser Arthur Tilg Herbert

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 5, 2008-05 ,pp. : 553-563

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic targeting of B7-H1 in breast cancer

By Hasan Amal Ghebeh Hazem Lehe Cynthia Ahmad Rasheed Dermime Said

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. : 1211-1225

Informa Healthcare

Access to resources Recommend Favorite

Targeting Cancer Stem Cells as a Therapeutic Approach in Liver Cancer

Current Gene Therapy, Vol. 15, Iss. 2, 2015-04 ,pp. : 161-170

Bentham Science Publishers

Access to resources Recommend Favorite

B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells

By Kristensen Nanna N. Schmidt Esben G. W. Rasmussen Susanne Balk-Møller Emilie Claesson Mogens H.

Immunopharmacology and Immunotoxicology, Vol. 35, Iss. 4, 2013-08 ,pp. : 505-513

Informa Healthcare

Access to resources Recommend Favorite